Ophthalmology · Irvine, CA
NPI
1750565032
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
118 Med Surge I
Irvine, CA, 92697
Phone (949) 824-0158
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,452
56 services
Medicare patients, 2024
30
Average age 69
Drug cost, 2024
$337K
6,022 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan Winarko prescribed most often to Medicare patients was Latanoprost, with 1,757 prescriptions and refills. In total Jonathan Winarko wrote 6,022 Medicare prescriptions that cost $337K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-30.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Latanoprost Generic | 1,757 | 4,704 | 640 | $23K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 1,281 | 4,028 | 446 | $32K |
| Brimonidine Tartrate Generic | 861 | 2,444 | 303 | $21K |
| Pilocarpine Hcl Generic | 470 | 1,428 | 154 | $20K |
| Prednisolone Acetate Generic | 362 | 454 | 192 | $12K |
| Timolol Maleate Generic | 196 | 611 | 76 | $3,278 |
| Bimatoprost Generic | 160 | 403 | 44 | $15K |
| Dorzolamide Hcl Generic | 160 | 487 | 52 | $4,263 |
| Travoprost Generic | 125 | 341 | 41 | $11K |
| Rhopressa Netarsudil Mesylate | 101 | 226 | 36 | $72K |
| Cyclosporine Generic | 95 | 119 | 30 | $11K |
| Vyzulta Latanoprostene Bunod | 66 | 137 | 18 | $37K |
| Methazolamide Generic | 47 | 93 | 21 | $7,693 |
| Acetazolamide Er Acetazolamide | 44 | 83 | 15 | $2,548 |
| Ketorolac Tromethamine Generic | 37 | 42 | 31 | $647 |
Brand drugs: 828 claims; generic drugs: 5,194 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jonathan Winarko were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.